Home > Qtrly Results > VENUS REMEDIES

VENUS REMEDIES
Quarterly Results Analysis [Mar2026]

VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Quarterly Results

Consolidated Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Revenues ₹259 Cr ₹180 Cr ₹193 Cr ₹132 Cr ₹198 Cr ₹177 Cr ₹170 Cr ₹109 Cr
Expenses ₹196 Cr ₹143 Cr ₹162 Cr ₹122 Cr ₹166 Cr ₹159 Cr ₹163 Cr ₹97 Cr
Operating Income ₹63 Cr ₹38 Cr ₹31 Cr ₹10 Cr ₹32 Cr ₹18 Cr ₹8 Cr ₹11 Cr
Other Income ₹5 Cr ₹3 Cr ₹2 Cr ₹9 Cr ₹4 Cr ₹2 Cr ₹8 Cr ₹2 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹7 Cr ₹7 Cr ₹6 Cr ₹6 Cr ₹5 Cr ₹5 Cr ₹6 Cr ₹6 Cr
Profit Before Tax ₹62 Cr ₹33 Cr ₹26 Cr ₹13 Cr ₹31 Cr ₹25 Cr ₹9 Cr ₹7 Cr
Profit After Tax ₹47 Cr ₹26 Cr ₹20 Cr ₹10 Cr ₹21 Cr ₹20 Cr ₹4 Cr ₹1 Cr
EPS ₹35.52 ₹19.13 ₹15.06 ₹7.18 ₹15.71 ₹14.66 ₹2.63 ₹0.91
Industry Peers & Returns1W1M1Y
VENUS REMEDIES 2.9% 84.3% 301.6%
SUN PHARMACEUTICAL INDUSTRIES 1.4% -4.5% 6.5%
DIVIS LABORATORIES 0.1% -2.5% -0.1%
TORRENT PHARMACEUTICALS -2.7% 1.2% 39.3%
CIPLA -2.3% -5.3% -9.8%
DR REDDYS LABORATORIES -0.5% -4.7% -5.4%
MANKIND PHARMA -0.3% -5.3% -0.9%
LUPIN -0.3% 0.6% 12.3%
ZYDUS LIFESCIENCES -4% 7.1% 10.2%

VENUS REMEDIES Quarterly Revenues

Revenues
Q-o-Q

43.90 %

Y-o-Y

31.24 %

Quarters Revenues % Change
Mar2026 ₹259 Cr
43.90
Dec2025 ₹180 Cr
-6.48
Sep2025 ₹193 Cr
46.13
Jun2025 ₹132 Cr
-33.27
Mar2025 ₹198 Cr
11.98
Dec2024 ₹177 Cr
3.77
Sep2024 ₹170 Cr
56.62
Jun2024 ₹109 Cr -

VENUS REMEDIES Quarterly Operating Profit

Operating Profit
Q-o-Q

69.06 %

Y-o-Y

100.16 %

Quarters Operating Profit % Change
Mar2026 ₹63 Cr
69.06
Dec2025 ₹38 Cr
21.19
Sep2025 ₹31 Cr
206.53
Jun2025 ₹10 Cr
-68.13
Mar2025 ₹32 Cr
75.86
Dec2024 ₹18 Cr
138.36
Sep2024 ₹8 Cr
-32.86
Jun2024 ₹11 Cr -
Operating Margins
Q-o-Q

17.49 %

Y-o-Y

52.53 %

Quarters Operating Margin% % Change
Mar2026 24.45%
17.49
Dec2025 20.81%
29.58
Sep2025 16.06%
109.66
Jun2025 7.66%
-52.21
Mar2025 16.03%
57.00
Dec2024 10.21%
129.95
Sep2024 4.44%
-57.18
Jun2024 10.37% -

VENUS REMEDIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

85.65 %

Y-o-Y

126.14 %

Quarters Profit After Tax % Change
Mar2026 ₹47 Cr
85.65
Dec2025 ₹26 Cr
27.07
Sep2025 ₹20 Cr
109.69
Jun2025 ₹10 Cr
-54.29
Mar2025 ₹21 Cr
7.14
Dec2024 ₹20 Cr
458.40
Sep2024 ₹4 Cr
187.70
Jun2024 ₹1 Cr -
PAT Margins
Q-o-Q

29.03 %

Y-o-Y

72.41 %

Quarters PAT Margin(%) % Change
Mar2026 18.31 %
29.03
Dec2025 14.19 %
35.92
Sep2025 10.44 %
43.41
Jun2025 7.28 %
-31.45
Mar2025 10.62 %
-4.32
Dec2024 11.1 %
438.83
Sep2024 2.06 %
83.93
Jun2024 1.12 % -

VENUS REMEDIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

85.68 %

Y-o-Y

126.10 %

Quarters EPS % Change
Mar2026 ₹35.52
85.68
Dec2025 ₹19.13
27.03
Sep2025 ₹15.06
109.75
Jun2025 ₹7.18
-54.30
Mar2025 ₹15.71
7.16
Dec2024 ₹14.66
457.41
Sep2024 ₹2.63
189.01
Jun2024 ₹0.91 -

You may also like the below Video Courses